PITTSBURGH, PA
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)CROI FOUNDATION, founded in 2008, is a community nonprofit in the Medical Research sector that reported $3.8M in total revenue in fiscal year 2023. Revenue decreased 16% compared to the prior year. Expenses of $4.5M exceeded revenue, resulting in a 17% operating deficit.
CROI FOUNDATION ORGANIZES AND PRODUCES AN ANNUAL CONFERENCE, THE "CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS," TO PROVIDE A FORUM FOR BASIC SCIENTIFIC AND CLINICAL INVESTIGATORS TO PRESENT, DISCUSS AND CRITIQUE THEIR INVESTIGATIONS INTO THE EPIDEMIOLOGY AND BIOLOGY OF HUMAN RETROVIRUSES AND THE DISEASES THEY PRODUCE. CROI FOUNDATION PROVIDES A FORUM FOR TRANSLATING LABORATORY AND CLINICAL RESEARCH INTO PROGRESS AGAINST THE AIDS EPIDEMIC. CROI FOUNDATION WAS FORMED IN 2008 TO ENSURE THE ONGOING SUCCESS OF THE CONFERENCE, WHICH WAS FIRST HELD IN 1993 UNDER THE AUSPICES OF ANOTHER NONPROFIT ORGANIZATION. CROI FOUNDATION IS ORGANIZED TO ENCOURAGE THE ADVANCEMENT OF SCIENCE, DISSEMINATE EDUCATIONAL INFORMATION AND TO PROVIDE A FORUM FOR WORLD-WIDE RESEARCHERS TO GATHER AND COLLABORATE. THE FOUNDATION ALSO SUPPORTS AND MAINTAINS WEB-BASED ENDURING MATERIALS, INCLUDING PROCEEDINGS FROM CURRENT AND PRIOR CONFERENCES, FOR USE BY RESEARCHERS INVOLVED IN THE INVESTIGATION OF RETROVIRUSES AND OPPORTUNISTIC DISEASES ASSOCIATED WITH THEM.
THE CROI FOUNDATION'S CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI) CONSISTENTLY ATTRACTS OVER 3,500 LEADING RESEARCHERS, CLINICIANS, AND GOVERNMENT AND INDUSTRY INVESTIGATORS IN...
THE CROI FOUNDATION'S CONFERENCE ON RETROVIRUSES AND OPPORTUNISTIC INFECTIONS (CROI) CONSISTENTLY ATTRACTS OVER 3,500 LEADING RESEARCHERS, CLINICIANS, AND GOVERNMENT AND INDUSTRY INVESTIGATORS IN DIVERSE BUT INTERRELATED AREAS OF HIV AND EMERGING PATHOGEN RESEARCH FROM AROUND THE WORLD TO A SCIENTIFICALLY FOCUSED CONFERENCE TO FACILITATE THEIR UNDERSTANDING OF AND INVESTIGATION INTO THE PATHOGENESIS, PREVENTION AND TREATMENT OF HIV, RELATED VIRUSES, OTHER OPPORTUNISTIC AND EMERGING PATHOGENS, AND THEIR COMPLICATIONS. CROI 2021 AND 2022 ADDED CORONAVIRUSES, SPECIFICALLY SARS-COV-2 AND COVID-19 TO THE EMERGING PATHOGENS THAT ARE ADDRESSED DURING THE CONFERENCE AND IN CROI 2023 ADDED MPOX AS AN EMERGING PATHOGEN ADDRESSED DURING THE CONFERENCE. THE CONFERENCE PROVIDES A FORUM FOR TRANSLATING LABORATORY AND CLINICAL RESEARCH INTO PROGRESS BY BRINGING TOGETHER LEADERS IN THE FIELD TO INTERACT WITH AND EDUCATE ONE ANOTHER REGARDING THE VERY LATEST RESULTS, TREATMENT METHODS AND STATE OF THE ART RESEARCH AND TECHNOLOGICAL ADVANCES. THE COVID-19 PANDEMIC REQUIRED A SHIFT TO A VIRTUAL CONFERENCE IN MARCH OF 2020 AND THIS NECESSITY CONTINUED IN 2021 AND 2022. THE 2021 AND 2022 CONFERENCES WERE HELD VIRTUALLY. THE COMPLEXITIES OF HAVING A VIRTUAL CONFERENCE RESULTED IN INCREASED ADMINISTRATIVE, AUDIOVISUAL, INFORMATION TECHNOLOGY AND LOGISTICAL COSTS, BUT THESE WERE GENERALLY OFFSET BY THE REDUCTION IN THE COSTS FOR TRAVEL AND ACCOMMODATIONS FOR ATTENDEES. THE CONFERENCE RETURNED TO AN IN-PERSON CONFERENCE IN 2023 AND IS NOW IN ITS 30TH YEAR, CONTINUING AS THE PREMIER HIGH LEVEL INTERNATIONAL CONFERENCE SUPPORTING THE ADVANCEMENT OF CUTTING-EDGE RESEARCH RELATED TO HIV, OTHER VIRAL AND EMERGING INFECTIONS OF GLOBAL SIGNIFICANCE, AND THEIR COMPLICATIONS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $3,828,110 | $4,560,258 | -0.2% |
| Expenses | $4,475,135 | $3,798,596 | +0.2% |
| Net Income | $-647,025 | $761,662 | -1.8% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ELAINE ABRAMS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SUSAN BUCHBINDER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JUDITH CURRIER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| SHARON HILLIER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JOHN MELLORS | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| LANDON MEYER | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| ROBERT SCHOOLEY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| DIANE HAVLIR | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| JAMES HOXIE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NICOLAS CHOMONT | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| CONSTANCE BENSON | PRESIDENT | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| JOHN COFFIN | SECRETARY/TREASURER | 1.00 |
Officer
Director
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $3,828,110 | $4,475,135 | $6,681,515 | $-647,025 |
| 2022 | $4,560,258 | $3,798,596 | $4,636,591 | $761,662 |
| 2021 | $2,423,542 | $2,148,518 | $4,544,772 | $275,024 |
| 2020 | $2,212,529 | $2,750,153 | $3,982,771 | $-537,624 |
| 2019 | $4,913,327 | $4,171,133 | $4,137,529 | $742,194 |
| 2018 | $4,131,084 | $4,767,097 | $2,987,621 | $-636,013 |
Compare CROI FOUNDATION with other nonprofits in Pennsylvania and across the country.